Acute Humanin Therapy Attenuates Myocardial Ischemia and Reperfusion Injury in Mice
Author(s) -
Radhika Muzumdar,
Derek M. Huffman,
John W. Calvert,
Saurabh Kumar Jha,
Yoni Weinberg,
Lingguang Cui,
Anjaemkal,
Gil Atzmon,
L. Klein,
Susheel Gundewar,
Sang Yong Ji,
Madhav Lavu,
Benjamin L. Predmore,
David J. Lefer
Publication year - 2010
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.110.205997
Subject(s) - medicine , myocardial infarction , reperfusion injury , ejection fraction , cardiology , ischemia , tetrazolium chloride , apoptosis , ventricular remodeling , evans blue , infarction , pharmacology , endocrinology , heart failure , chemistry , biochemistry
Humanin (HN), an endogenous antiapoptotic peptide, has previously been shown to protect against Alzheimer's disease and a variety of cellular insults. We evaluated the effects of a potent analog of HN (HNG) in an in vivo murine model of myocardial ischemia and reperfusion.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom